Page last updated: 2024-08-26

deoxypyridinoline and Hormone-Dependent Neoplasms

deoxypyridinoline has been researched along with Hormone-Dependent Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duncan, WE; Harding, P; Howard, RS; McLeod, DG; Preston, DM; Torréns, JI1

Other Studies

1 other study(ies) available for deoxypyridinoline and Hormone-Dependent Neoplasms

ArticleYear
Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
    Prostate cancer and prostatic diseases, 2002, Volume: 5, Issue:4

    Topics: Absorptiometry, Photon; Adenocarcinoma; Aged; Amino Acids; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Biomarkers; Bone Density; Bone Remodeling; Calcium; Drug Therapy, Combination; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Neoplasms, Hormone-Dependent; Nitriles; Orchiectomy; Osteoporosis; Prospective Studies; Prostatic Neoplasms; Testosterone; Tosyl Compounds

2002